Bhavsar S
Front Oncol. 2023; 13:1196861.
PMID: 37274289
PMC: 10233040.
DOI: 10.3389/fonc.2023.1196861.
Niculescu V
Med Oncol. 2023; 40(4):114.
PMID: 36892717
DOI: 10.1007/s12032-023-01983-1.
Jacobson J, Clark R, Chung D
Children (Basel). 2023; 10(2).
PMID: 36832517
PMC: 9955866.
DOI: 10.3390/children10020388.
Eibl R, Schneemann M
Biology (Basel). 2023; 12(2).
PMID: 36829544
PMC: 9952923.
DOI: 10.3390/biology12020267.
Durrani S, Tebha S, Qamar M, Nathani K, Harrison D, Aljameey U
Neurosurg Rev. 2023; 46(1):57.
PMID: 36786867
DOI: 10.1007/s10143-023-01960-2.
Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma.
Chen C, Hu Y, Chien Y, Huang W, Wu C, Tsai C
Oxid Med Cell Longev. 2023; 2023:8753309.
PMID: 36644580
PMC: 9839411.
DOI: 10.1155/2023/8753309.
Neuroblastoma: When differentiation goes awry.
Zeineldin M, Patel A, Dyer M
Neuron. 2022; 110(18):2916-2928.
PMID: 35985323
PMC: 9509448.
DOI: 10.1016/j.neuron.2022.07.012.
MYCN in Neuroblastoma: "Old Wine into New Wineskins".
Braoudaki M, Hatziagapiou K, Zaravinos A, Lambrou G
Diseases. 2021; 9(4).
PMID: 34842635
PMC: 8628738.
DOI: 10.3390/diseases9040078.
The Non-coding Side of Medulloblastoma.
Laneve P, Caffarelli E
Front Cell Dev Biol. 2020; 8:275.
PMID: 32528946
PMC: 7266940.
DOI: 10.3389/fcell.2020.00275.
Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth.
Yao M, Ventura P, Jiang Y, Rodriguez F, Wang L, Perry J
Cell. 2020; 180(3):502-520.e19.
PMID: 31983537
PMC: 7259679.
DOI: 10.1016/j.cell.2019.12.024.
Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.
Lee A, Shih Y, Zhou F, Chao T, Lee H, Liao Y
J Mol Med (Berl). 2019; 97(3):325-339.
PMID: 30612140
DOI: 10.1007/s00109-018-1730-x.
RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.
Singhal S, Nagaprashantha L, Singhal P, Singhal S, Singhal J, Awasthi S
Pharm Res. 2017; 34(8):1673-1682.
PMID: 28386633
DOI: 10.1007/s11095-017-2154-y.
Adult Neuroblastoma-Case Report and Literature Review.
Godkhindi V, Basade M, Khan K, Thorat K
J Clin Diagn Res. 2017; 10(12):ED01-ED02.
PMID: 28208865
PMC: 5296438.
DOI: 10.7860/JCDR/2016/20237.9080.
The flowering of pathology as a medical discipline in Boston, 1892-c.1950: W.T. Councilman, FB Mallory, JH Wright, SB Wolbach and their descendants.
Louis D, OBrien M, Young R
Mod Pathol. 2016; 29(9):944-61.
PMID: 27312063
DOI: 10.1038/modpathol.2016.91.
Penetrating enemy territory: Soluble PCNA-peptides stress out MYCN-overexpressing neuroblastomas.
Bielinsky A
EBioMedicine. 2016; 2(12):1844-5.
PMID: 26844252
PMC: 4703722.
DOI: 10.1016/j.ebiom.2015.12.012.
Expression of the erythropoietin receptor by germline-derived cells - further support for a potential developmental link between the germline and hematopoiesis.
Suszynska M, Poniewierska-Baran A, Gunjal P, Ratajczak J, Marycz K, Kakar S
J Ovarian Res. 2014; 7:66.
PMID: 24982693
PMC: 4074848.
DOI: 10.1186/1757-2215-7-66.
Neuroblastoma and MYCN.
Huang M, Weiss W
Cold Spring Harb Perspect Med. 2013; 3(10):a014415.
PMID: 24086065
PMC: 3784814.
DOI: 10.1101/cshperspect.a014415.
Tumor stem cells: A new approach for tumor therapy (Review).
Meng M, Zhao X, Ning Q, Hou L, Xin G, Liu L
Oncol Lett. 2012; 4(2):187-193.
PMID: 22844351
PMC: 3402726.
DOI: 10.3892/ol.2012.730.
Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison.
Rothenberg A, Berdon W, DAngio G, Yamashiro D, Cowles R
Pediatr Radiol. 2008; 39(2):155-60.
PMID: 19034443
DOI: 10.1007/s00247-008-1062-z.
Neuropathology for the neuroradiologist: rosettes and pseudorosettes.
Wippold 2nd F, Perry A
AJNR Am J Neuroradiol. 2006; 27(3):488-92.
PMID: 16551982
PMC: 7976948.
